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SUMMARY
An environmental surveillance programme was developed to determine whether water supplies
could be a source of Burkholderia pseudomallei as noted during previous melioidosis outbreak
investigations. Water supplies to communities in the three northern Australian jurisdictions
(Western Australia, Northern Territory and Queensland) were sampled periodically during 2001
and 2002. Water and soil samples were collected from communities known to have had recent
culture-positive melioidosis cases and nearby communities where no cases had been diagnosed.
Clinical isolates of B. pseudomallei obtained from northern Australian patients during 2001
and 2002 were compared with the environmental B. pseudomallei isolates by ribotyping and
pulsed-ﬁeld gel electrophoresis. B. pseudomallei was isolated from 11 distinct locations, all in
the Northern Territory, seven of which were associated with culture-positive melioidosis cases
(>1 case at three locations). Water was implicated as a possible environmental source of
melioidosis in six locations. A variety of free-living amoebae including Acanthamoeba and
Hartmannella spp. that are potential hosts to B. pseudomallei were recovered from environmental
specimens. Culturable B. pseudomallei was not found to be widely dispersed in the
environments sampled.
INTRODUCTION
Melioidosis, a potentially fatal bacterial infection
endemic in northern Australia and Southeast Asia, is
thought to occur as a result of exposure to soil or
water contaminated with Burkholderia pseudomallei
[1]. Most B. pseudomallei infection occurs during
the wet season [2]. The most likely means of
transmission are direct inoculation, inhalation and
ingestion [3].
A small case cluster of septicaemic melioidosis
occurred in a remote northwestern Australian com-
munity just prior to the wet season in late 1997 [4].
An epidemiological, environmental and laboratory
investigation implicated the community’s drinking
water supply as a source of B. pseudomallei. Environ-
mental control measures targeted at the suspected
source appeared to eﬀectively prevent any further
cases of acute, septicaemic infection. Subsequent
environmental investigations identiﬁed the water
treatment plant as the likely primary source of
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B. pseudomallei [5]. The unchlorinated community
water supply was also implicated as a likely source
of B. pseudomallei in another case-cluster in a remote
community in the Northern Territory, which included
four fatal cases [6].
A collaborative environmental surveillance project
involving the three northern Australian jurisdictions
Western Australia (WA), Northern Territory (NT)
and Queensland (Qld) was established to follow-up
these observations and determine whether drinking
water supplies are a potential source of melioidosis in
other parts of northern Australia.
METHODS
Clinical isolate collection
Clinical isolates were obtained by the three collabor-
ating centres from cases of melioidosis diagnosed in
their respective jurisdictions. Presumptive diagnoses
(i.e. those made on clinical signs or by demonstration
of seroconversion in the absence of positive cultures)
were excluded from further analysis and environ-
mental follow-up. Serological data were checked
periodically to ensure that undeclared positive cul-
tures had been referred to the collaborating centres.
These centres also acted as reference laboratories for
conﬁrmation of B. pseudomallei identiﬁcation, thus
assisting the collection and collation of clinical iso-
lates. Melioidosis was a notiﬁable disease in all three
jurisdictions for the period under study.
Environmental sampling
Sample locations were determined by the place of
residence of the clinical cases at the time of diagnosis.
The communities selected for sampling had one or
more dry season cases of culture-conﬁrmed, septi-
caemic melioidosis. Communities where more than
one acute culture-positive case had been conﬁrmed
during the wet season and adjacent communities
where no cases had been documented were sampled.
Multiple locations were sampled in quick succession
to allow control and test samples to be compared as
closely as possible, as far as geography permitted.
Potable water, surface and rhizosphere soil were col-
lected from locations suitable for human exposure by
direct contact, ingestion, inoculation or inhalation.
Water samples of 250 ml to 2 litres were collected.
Outlet pipes were sterilized and water run for 5 min
prior to collection to reduce the risk of contamination
by soil or dust. When water samples were collected
from surface water, the bottle was submerged
approximately 10 cm below the surface then opened,
ﬁlled with the sample and then closed before being
removed. Soil samples were collected at catchment
area sites where water samples were collected and
around the residences of melioidosis patients. The
ﬁrst 2–3 cm of soil was scraped away from the surface
prior to collecting samples; one at a depth of
10–15 cm, and where possible another at 15–30 cm.
For root soil samples, the soil was collected 60 cm
from the stem of the plant.
As there were diﬀerences in sample processing
methods between the three centres, a proportion of
environmental samples from NT and Qld were col-
lected in duplicate for analysis by the WA centre in
order to assess consistency of results.
Water testing
At each sample site the temperature, pH and residual
and free chlorine levels of the water were measured.
Water samples were prepared for culture by mem-
brane ﬁltration. The membranes were added to selec-
tive broths and incubated at 37 xC. The cultures were
spread on Ashdown’s medium [7] and BPSA plates
[8]. The plates were examined after 48 h incubation at
37 xC and after a further 5 days at room temperature
(Table 1).
Water samples were analysed for free-living
amoebae by centrifugation using a standard method.
In brief, 250 ml of the water sample was centrifuged
with live AWQCEscherichia coli. The pellet was resus-
pended in 2 ml of the supernatant and spread on NNA
plates. The plates were examined for areas of lysis
after 72 h incubation at 42 xC. A light microscope was
used to identify the genus of the amoebae detected.
Soil testing
The pH of each soil sample was measured. Soil
samples were prepared for culture by shaking the
soil in demineralized water and allowing it to sedi-
ment. The supernatant was added to selective broths
and incubated at 37 xC. The cultures were spread on
Ashdown’s medium and BPSA plates. The plates were
examined after 48 h incubation at 37 xC and after a
further 5 days at room temperature (Table 1).
Identiﬁcation of B. pseudomallei
Colonies showing morphology typical of B. pseudo-
mallei were tested for oxidase production and
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Gram-stained (Table 1). Gentamicin resistance was
established by disc diﬀusion testing using 10 mg/ml
gentamicin discs on blood agar. Deﬁnitive B. pseudo-
mallei identiﬁcation was determined by substrate
utilization [API20NE strips, Microscan1 Walk-
away 96 (Dade Diagnostics, West Sacramento, CA,
USA) and Biome´rieux Vitek (Baulkham Hills, NSW,
Australia)], in-house agglutination [9] and polymerase
chain reaction [10–13].
Molecular typing of B. pseudomallei
Molecular typing was performed on isolates identiﬁed
as B. pseudomallei using DNA macrorestriction and
ribotyping as described previously [14]. In brief,
pulsed-ﬁeld gel electrophoresis (PFGE) was per-
formed using XbaI and loaded gels were electro-
phoresed with a pulse time and ramp of 5.5–52 s for
20.2 h at 200 V. An automated EcoRI protocol (Ribo-
PrinterTM, Dupont-Qualicon, Wilmington, DE, USA)
was used for ribotyping. Gel images and ribotype
patterns were collated and analysed using a molecular
typing analytical software package (Bionumerics
Version 1.0, Applied Maths, Kortrijk, Belgium).
RESULTS
There were 41 human cases of culture-conﬁrmed
melioidosis in northern Australia during 2001 and 43
in 2002, 62% of which were from the NT, 30% from
Qld and 8% fromWA. These cases are less in number
than in 2000 and coincide with drier years for the
three participating jurisdictions. In 2001 the diﬀerence
in rainfall was most notable in Qld where several
areas within the state had a total rainfall well below
average, based on Bureau of Meteorology data col-
lected from 1961 to 1990. In 2002, areas in all three
jurisdictions had low total rainfall readings.
A total of 745 environmental samples were col-
lected across northern Australia during the study
period (Table 2), 52% of which were water samples
and 48% soil samples. All samples collected in Qld,
and 45% of the samples collected in the NT were ana-
lysed in duplicate. Duplicate analysis revealed a stat-
istically signiﬁcant agreement in the results obtained
by each jurisdiction (Fisher’s exact test, P=0.0005),
however, samples were more often found to be posi-
tive by one centre than by both (Table 3).
Eleven water samples and 11 soil samples from the
NT were found to be culture-positive for B. pseudo-
mallei (Table 4). Both of the two positive water sam-
ples from 2001 (NTE003 and NTE265) were collected
during the wet season from bores on NT properties
where animal infection occurred (pigs and a dog re-
spectively). Two positive soil samples were collected
from another NT property where goats had melioi-
dosis. Two soil samples collected for control purposes
at diﬀerent depths below the surface of a construction
Table 1. Laboratory methods
Collaborating centre
WA NT Qld
Water testing
Volume ﬁltered 250 ml 1–2 l 250 ml
Membrane pore size 0.22 mm 0.45 mm 0.22 mm
Selective broths TSB* TSB* and Ashdown’s broth# TSB*
Broths monitored 7 d 14 d 2 d
Soil testing
Quantity tested 5 g 20 g 10 g
Shaking 4 h Overnight 4 h
Selective broth step (1) TSB* (1) TSB* and Ashdown’s broth# (1) TSB*
(2) Ashdown’s broth# (2) Ashdown’s broth#
Broths monitored 7 d 14 d 2 d
Identiﬁcation of (1) Oxidase test (1) Oxidase test (1) Oxidase test
B. pseudomallei (2) Gram stain (2) Gram stain (2) Biome´rieux Vitek
(3) Gentamicin resistance (3) In-house agglutination [9]
(4) API20NE (3) Microscan1Walkaway 96
(5) Nested PCR [10–12] (4) PCR [13]
* Contains 10 mg/ml gentamicin.
# Contains 50 mg/l colistin.
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site associated with no clinical cases contained B.
pseudomallei (NTE065 and NTE066). During the
2001 dry season soil samples were collected around
the residences of two NT human melioidosis cases.
Both properties were grassed and watered regularly
at the sites of four positive soil samples (NTE086,
NTE090, NTE098 and NTE100). The ﬁfth positive
soil sample was from an area exposed to regular
vehicle traﬃc (NTE102).
The ﬁrst positive water sample for 2002 was col-
lected after the wet season ended, from a shaded area
at the edge of a running creek in the NT (NTE270).
Six of the positive water samples collected in the 2002
dry season were from bores at two NT residences.
One of the residences belonged to a human melioi-
dosis case and had B. pseudomallei in water from
the bore-water holding tank (NTE280) and in water
samples taken from an irrigation pipe at the start and
end of a 2-month period (NTE273 and NTE282). The
water from a bore ﬁlter system used to ﬁlter the bore
water for household use was also positive for B.
pseudomallei (NTE279 and NTE114). The other resi-
dence was not connected with a case of melioidosis
but had B. pseudomallei-positive water collected from
the bore-water holding tank (NTE289) and the bore-
head tap (NTE290). At the beginning of the 2002 wet
season a water sample collected by the NT local water
authority from a bore-head tap at a diﬀerent location
was also positive for B. pseudomallei (NTE326).
Other Burkholderia species with phenotypic simila-
rities to B. pseudomallei were isolated from 4 WA
water samples, 2 WA soil samples, 10 NT water
samples, 47 NT soil samples and 22 Qld soil samples.
These were excluded on the basis of PCR results.
Of the 315 water samples tested for free-living
amoebae, 22, 44 and 4% of the samples collected
from WA, NT and Qld respectively contained
amoebae. Hartmannella was the most common genus
found, and was detected in 60% of the positive water
samples. Acanthamoeba was the next most common
and was detected in 39% of the positive water
samples.
Molecular typing results
PFGE and ribotype patterns of 24 environmental
B. pseudomallei isolates (12 from 11 water samples and
12 from 11 soil samples) were compared with 9 related
clinical isolates and 26 unrelated clinical isolates
for 2001 (6 from WA, 13 from the NT and 7 from
Qld). The Bionumerics molecular typing analytical
software generated a composite dendrogram demon-
strating the degree of relatedness between the 59
B. pseudomallei isolates (Fig.).
The two isolates from positive water samples col-
lected in 2001 from NT bores associated with animal
infections (NTE003 and NTE265) grouped together
in a distinct cluster (Cluster A) featuring the associ-
ated porcine and canine clinical isolates (NTC011,
NTC012, NTC014, NTC015, NTC016 and NTC017).
The two B. pseudomallei isolates from soil samples
collected around a NT goat farm (NTE055 and
NTE057) and the associated caprine clinical isolate
(NTC009), a soil connected with a primate case of
melioidosis (NTE076), two representative clinical iso-
lates from this jurisdiction (NTU028 and NTU034)
and an isolate from one of ﬁve water samples
Table 3. Comparison of duplicate specimen results
also tested in WA
B. pseudomallei result
WA results +* x# Total
+ 4 11 15
x 7 340 347
Total 11 351 362
* B. pseudomallei isolated from NT or Qld sample.
# B. pseudomallei not isolated from NT or Qld sample.
Table 2. Environmental sample collection
WA NT Qld Total
Sample runs performed 24 (30%) 40 (50%) 16 (20%) 80
Water samples collected 182 (47%) 130 (34%) 73 (19%) 385
(no. processed in duplicate) (0) (103) (73) (176)
Soil samples collected 44 (12%) 154 (43%) 162 (45%) 360
(no. processed in duplicate) (0) (24) (162) (186)
Total samples collected 226 (30%) 284 (38%) 235 (32%) 745
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collected from the residence of a NT human case
(NTE273) were all grouped in this cluster. The iso-
lates from the other four water samples from this site,
but collected at a later date (NTE279, NTE280,
NT282 and NT114), did not group with this cluster
and had a similarity of at least 85% to each other. All
were distinct from the geographically related human
clinical isolate (NTC83).
A second cluster of isolates was evident in the den-
drogram (Cluster B). This consisted of two of the four
B. pseudomallei isolates found in soil samples col-
lected around the residence of a human case (NTE090
and NTE102), the respective clinical isolate
(NTC008), a soil isolate from the residence of a
second human case (NTE086), and three unrelated
clinical isolates from the same jurisdiction (NTU033,
NTU035 and NTU036).
Though the unrelated clinical isolates often
grouped with other clinical isolates from the same
jurisdiction, these isolates were genetically diverse.
Moreover, some similarities between isolates from the
three jurisdictions were evident.
DISCUSSION
The previous ﬁnding that potable water supplies
contained B. pseudomallei that were indistinguishable
from clinical isolates in two separate melioidosis
outbreaks highlighted the potable water supply as a
potential source of the infection. The present surveil-
lance project was established to follow-up the ﬁndings
of those two outbreak investigations in a structured,
prospective study.
Table 4. Sites positive for B. pseudomallei
Jurisdiction
sampled Sample site
Type of
case Sample ID
Date of
collection
Type of
sample
Species of
Burkholderia Clinical isolate
NT Piggery Porcine NTaEb003 23.ii.01 Water B. pseudomallei NTCc011, NTC012,
NTC014, NTC015,
NTC016
NT Goat farm Caprine NTE055 30.iii.01 Soil B. pseudomallei,
B. multivorans
NTC009
NTE057 30.iii.01 Soil B. pseudomallei
NT Construction No cases NTE065 2.v.01 Soil B. pseudomallei
site NTE066 2.v.01 Soil B. pseudomallei
NT Animal park Primate NTE068 8.v.01 Soil B. pseudomallei n.a.
NTE076 31.v.01 Soil B. pseudomallei
NT Residence Human NTE086 4.vii.01 Soil B. pseudomallei,
B. cepacia
n.a.
NT Residence Human NTE090 11.vii.01 Soil B. pseudomallei,
B. cepacia
NTC008
NTE098 11.vii.01 Soil B. pseudomallei
NTE100 11.vii.01 Soil B. pseudomallei
NTE102 11.vii.01 Soil B. pseudomallei
NT Residence Canine NTE265 13.xii.01 Water B. pseudomallei NTC017
NT Running creek No cases NTE270 26.iv.02 Water B. pseudomallei
NT Residence Human NTE273 28.v.02 Water B. pseudomallei NTC83
NTE279 8.viii.02 Water B. pseudomallei
NTE280 8.viii.02 Water B. pseudomallei
NTE282 8.viii.02 Water B. pseudomallei
NTE114 8.viii.02 Water B. pseudomallei
NT Residence No cases NTE289 23.viii.02 Water B. pseudomallei
NTE290 23.viii.02 Water B. pseudomallei
NT Water authority
sample point
No cases NTE326 27.xi.02 Water B. pseudomallei
a Isolated from the Northern Territory, as indicated by ‘NT’ in preﬁx.
b Isolated from an environmental sample, as indicated by ‘E’ in preﬁx.
c Isolated from a clinical sample, as indicated by ‘C’ in preﬁx.
n.a., Not available.
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Unusually dry weather was associated with lower
than average totals of culture-conﬁrmed melioidosis
cases during 2001 and 2002. Of those occurring in
locations that were accessible to the project team (48),
six clinical isolates were closely related by molecular
typing to B. pseudomallei recovered from associated
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Fig. Composite dendrogram of PFGE and ribotype patterns for 59 B. pseudomallei isolates. Isolate names represent the
jurisdiction where the isolate was obtained (NT, Northern Territory ; WA, Western Australia ; QLD, Queensland) and
the nature of the sample from which it was isolated (E, environmental sample ; C, clinical sample related to an environmental
site sampled ; U, clinical sample unrelated to the environmental sites sampled).
818 T. J. J. Inglis and others
water specimens. This equated with two of the four
NT locations where clinical isolates of B. pseudomallei
were linked by molecular typing to associated en-
vironmental isolates. In both instances, the clinical
isolates were from infections in animals.
Great care was taken to avoid making spurious
links between environmental and clinical isolates.
Genotypic conﬁrmation of all suspect Burkholderia
spp. was performed using PCR-based protocols.
Molecular typing of B. pseudomallei was then per-
formed using two distinct methods, automated ribo-
typing and PFGE. While the stringency of this
approach may have reduced the numbers of water
supplies implicated as possible B. pseudomallei
sources, it allowed a greater conﬁdence in the links
that were established. Moreover, the collection and
collation of B. pseudomallei genotyping data from
across northern Australia has led to the creation of
a library of typing data that will assist the molecular
epidemiological assessment of clinical or environ-
mental isolates at a later stage.
The diﬀerences in methods used to isolateB. pseudo-
mallei from environmental specimens reﬂected the
practical diﬃculties of conveying samples from re-
mote communities to collaborating centres. However,
less than 2% of samples analysed in duplicate were
found to be positive by the NT or Qld laboratories
and negative by the WA laboratory after samples
were transported there. This decrease in analytical
sensitivity could be attributed to transport, diﬀerence
in sample volumes and subtle diﬀerences in methods
used by each centre.
While B. pseudomallei was recovered from several
locations in the NT, we were unable to ﬁnd evidence
to support the unattributed but often repeated as-
sertion that B. pseudomallei is widely distributed in
the environment. Given the measures taken to recover
B. pseudomallei from the environment, including
potential intracellular locations, the extent of en-
vironmental contamination is remarkably limited in
locations associated with clinical cases. If our pre-
liminary ﬁndings are repeated in the later stages of
this study, it would appear that a patchy environ-
mental distribution with pockets of culturable bac-
teria is more likely. The alternative explanation that
has yet to be disproved is that the species is more
widely distributed in either a viable but non-cultur-
able form or is present in a sequestered (e.g. deep
rhizosphere or even intracellular) habitat. Viable
B. pseudomallei was not recovered from any amoebic
trophozoite lysate preparations during this stage of
the project, nor was the species isolated from any root
lysate preparations.
In human cases of melioidosis it is often possible to
surmise a likely route of initial disease transmission.
Even with this information it was not possible to do
more than speculate on a likely mode of ﬁnal trans-
mission in the previously documented water-related
outbreaks. In the present study, the available infor-
mation does not allow us to attempt to distinguish soil
from water exposure in the cases linked to positive
environmental cultures. Nor is it possible to establish
whether soil or water was contaminated ﬁrst, or if
both occurred through simultaneous contamination
from an external source. Nevertheless, none of the
positive water supplies were chlorinated and would
thus not have been protected against downstream
dissemination of B. pseudomallei. These results add to
previous observations of water-supply contamination
by B. pseudomallei. In none of those was chlori-
nation continuously and properly maintained. In the
majority of the reported cases, the water had not been
treated with chlorine at all.
The number of water-related melioidosis cases were
too small to allow useful analysis of water quality,
hydrological and geological data. It is expected that
the additional cases expected during the remainder of
this surveillance project will allow such an analysis.
From the available data it is clear that the detection of
B. pseudomallei in a potable water specimen is un-
common and has potential public health signiﬁcance.
It remains to be seen whether potable water supplies
in northern Australia need periodic testing for
B. pseudomallei.
As a result of the ﬁrst stage of the northern
Australian melioidosis surveillance project, cases of
melioidosis have been linked to potential environ-
mental sources of infection by systematic environmen-
tal sampling, careful bacteriological and molecular
typingmethods. In two instances of sporadic infection,
water has been identiﬁed as a potential source and in
both of these the source was not chlorinated. Pri-
orities for the remainder of this investigation are the
identiﬁcation of other B. pseudomallei-contaminated
water supplies, possibly by further improvement of
environmental recovery methods, and determination
of the role that free-living amoebae such as Acanth-
amoeba and Hartmannella spp. may play at these
locations. Measures are being taken in the later stages
of this study to ensure that conventional water-
quality data and local geographical factors such as
hydrological and geological features can be used to
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understand the ecology of B. pseudomallei distri-
bution in the northern Australian environment.
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